DrugPatentWatch Database Preview
Patent: 9,144,585
Summary for Patent: 9,144,585
| Title: | Isolated mesenchymal progenitor cells and extracellular matrix produced thereby |
| Abstract: | Provided are methods of isolating an extracellular matrix from mesenchymal progenitor cells which are characterized by a reduced differentiation ability into an adipogenic lineage as compared to adipose-derived mesenchymal stem cells. Also provide isolated extracellular matrix and hybrid devices comprising electrospun elements and extracellular matrix which can be used for various tissue regeneration, repair and reconstruction surgeries. |
| Inventor(s): | Itskovitz-Eldor; Joseph (Haifa, IL), Shtrichman; Ronit (Haifa, IL), Zussman; Eyal (Haifa, IL), Barak; Efrat (Nofit, IL) |
| Assignee: | Technion Research & Development Foundation Limited (Haifa, IL) |
| Application Number: | 13/812,552 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,144,585
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | Technion Research & Development Foundation Limited (Haifa, IL) | 2030-07-27 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,144,585
| Country | Patent Number | Publication Date |
|---|---|---|
| Japan | 2013535966 | Sep 19, 2013 |
| United States of America | 2013130387 | May 23, 2013 |
| United States of America | 2013230601 | Sep 05, 2013 |
| World Intellectual Property Organization (WIPO) | 2012014205 | Feb 02, 2012 |
| World Intellectual Property Organization (WIPO) | 2012014207 | Feb 02, 2012 |
| >Country | >Patent Number | >Publication Date |
